Project Grant R01EB037186
- This federal Project Grant award of $422,623.00, provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286), supports the development of a high-fidelity brain perfusion MRI technique for newborns less than one week of age. The project, led by The Johns Hopkins University, aims to address the critical challenge of measuring cerebral blood flow...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $459,264 Project Grant to The Johns Hopkins University under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award, which runs from Apr 8, 2025 to Feb 28, 2029, will support research and development to enhance resolution and contrast in magnetic resonance (MR) neuroimaging. This is intended to help standardize the appearance of MR neuroimages...
- This $691,935 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders supports research to develop quantitative diffusion MRI methods for predicting neurodevelopmental outcomes in infants with hypoxic ischemic brain injury. The project aims to analyze diffusion MRI data from two large datasets - the High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL)...
- This $1,336,000 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" program supports the development of a rapid, motion-robust, and low-gadolinium MRI technology for pediatric brain tumors. The key objectives are to (1) develop cutting-edge technologies for rapid, motion-robust, and quantitative MRI scans to reduce sedation needs...
- The federal Project Grant award of $884,573 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) is being used by Brigham & Women's Hospital Inc. to develop an "Abbreviated Yet Enhanced Neuro MRI Protocol." The project aims to reduce brain MRI exam duration by roughly three-fold while capturing quantitative and qualitative MRI contrasts as...
- The U.S. National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,758,475 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop next-generation in-vivo diffusion MRI (dMRI) technologies. This funding will enable MGH to create novel acquisition methods that can provide significant...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,161,839 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to the University of Wisconsin System for the project "MRI Technology for Greater Efficiency and Improved Value". The overall goal is to design technologies that improve the value of MRI by enhancing efficiency, accessibility, safety, and user experience. Key...
- This federal Project Grant award, titled "Fingerprinting Spatiotemporal Patterns of Brain Maturation with Combined Diffusion-Relaxometry Microstructure Imaging," is funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The $134,730 award, effective August 1, 2025, supports research at The General Hospital Corporation, doing business as...
- This $567,977 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), will fund research to develop wearable, optically pumped magnetometer-based magnetoencephalography (OPM-MEG) technology. The goal is to optimize this non-invasive neuroimaging approach for simultaneously recording brain activity in caregiver-infant dyads during...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $147,486 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the Massachusetts Institute of Technology (MIT) from July 1, 2025 to June 30, 2027. The grant funds the development of a novel Magnetic Resonance Imaging (MRI) method to concurrently measure brain tissue displacement, blood dynamics, and cerebrospinal fluid (CSF) flow in humans. This research...
This Project Grant award, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to significantly enhance quantitative magnetic resonance imaging (MRI) technology for in-vivo analysis of neurovascular structures and the early developing brain's response to perinatal stroke. The $511,583 award, with a project period from August 1, 2025 to May 31, 2029, will support the development of a novel motion- and distortion-robust quantitative MRI approach using 3D motion-robust radial multi-echo MRI combined with advanced image processing and reconstruction techniques. This innovative approach aims to correct for motion and reconstruct high-resolution quantitative data, enabling detailed visualization of neurovascular structure in small fetal and neonatal brains, which is critical for understanding early brain development and common neurodevelopmental abnormalities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 8/27/25 | ||
| Not listed | $511.6k | 7/29/25 |